TruBridge Inc (TBRG)
8.91
-0.34
(-3.68%)
USD |
NASDAQ |
May 17, 16:00
8.91
0.00 (0.00%)
After-Hours: 20:00
TruBridge Research and Development Expense (Quarterly): 10.69M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 10.69M |
| December 31, 2023 | 10.35M |
| September 30, 2023 | 9.778M |
| June 30, 2023 | 10.60M |
| March 31, 2023 | 8.352M |
| December 31, 2022 | 9.001M |
| September 30, 2022 | 7.987M |
| June 30, 2022 | 8.107M |
| March 31, 2022 | 8.064M |
| December 31, 2021 | 10.21M |
| September 30, 2021 | 7.70M |
| June 30, 2021 | 6.469M |
| March 31, 2021 | 8.429M |
| December 31, 2020 | 8.267M |
| September 30, 2020 | 8.549M |
| June 30, 2020 | 8.371M |
| March 31, 2020 | 8.271M |
| December 31, 2019 | 9.177M |
| September 30, 2019 | 9.158M |
| Date | Value |
|---|---|
| June 30, 2019 | 9.297M |
| March 31, 2019 | 9.228M |
| December 31, 2018 | 8.996M |
| September 30, 2018 | 9.305M |
| June 30, 2018 | 9.314M |
| March 31, 2018 | 8.757M |
| December 31, 2017 | 8.995M |
| September 30, 2017 | 8.25M |
| June 30, 2017 | 8.414M |
| March 31, 2017 | 8.077M |
| December 31, 2016 | 5.329M |
| September 30, 2016 | 8.397M |
| June 30, 2016 | 8.179M |
| March 31, 2016 | 7.19M |
| December 31, 2015 | 3.522M |
| September 30, 2015 | 3.555M |
| June 30, 2015 | 3.57M |
| March 31, 2015 | 3.582M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
6.469M
Minimum
Jun 2021
10.69M
Maximum
Mar 2024
8.841M
Average
8.489M
Median
Research and Development Expense (Quarterly) Benchmarks
| Veradigm Inc | 23.68M |
| Streamline Health Solutions Inc | 1.394M |
| LifeMD Inc | 2.087M |
| PetMed Express Inc | -- |
| LENZ Therapeutics Inc | 10.54M |